{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:55:05Z","timestamp":1790009705282,"version":"4.0.1"},"reference-count":19,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,4,1]]},"DOI":"10.1185\/030079907x182185","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T23:39:18Z","timestamp":1173224358000},"page":"793-801","source":"Crossref","is-referenced-by-count":148,"title":["A double-blind study evaluating the long-term safety of varenicline for smoking cessation"],"prefix":"10.1185","volume":"23","clinical-trial-number":[{"clinical-trial-number":"nct00143299","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kathryn E.","family":"Williams","sequence":"first","affiliation":[{"name":"Pfizer Global Research & Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Reeves","sequence":"additional","affiliation":[{"name":"Pfizer Global Research & Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Clare B.","family":"Billing","sequence":"additional","affiliation":[{"name":"Pfizer Global Research & Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Pennington","sequence":"additional","affiliation":[{"name":"Pfizer Global Research & Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Gong","sequence":"additional","affiliation":[{"name":"Pfizer Global Research & Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2007,3,5]]},"reference":[{"key":"CIT0001","unstructured":"The health consequences of smoking: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2004"},{"key":"CIT0002","unstructured":"The health benefits of smoking cessation: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Centers for Disease Control, 1990"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"Henningfield JE, Fant RV, Buchhalter AR, et al. Pharmacotherapy for nicotine dependence. CA Cancer J Clin 2005;55:281\u201399; quiz 322\u20133, 5","DOI":"10.3322\/canjclin.55.5.281"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1021\/jm050069n"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.64"},{"key":"CIT0006","author":"Fiore MC","year":"2000","journal-title":"Treating tobacco use and dependence: Clinical practice guideline. Rockville"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(78)90024-2"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1080\/14622200310001656993"},{"key":"CIT0009","unstructured":"AIHW. 2001 National Drug Strategy Household Survey: Detailed findings. Canberra: AIHW (Drug Statistics Series No.11); 2002. Report No.: cat. no. PHE 41"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.47"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.56"},{"key":"CIT0012","first-page":"205","volume":"11","author":"Abelin T","year":"1989","journal-title":"Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511023331807"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262002-00005"},{"key":"CIT0015","unstructured":"Zyban. Summary of product characteristics. Research Triangle Park, North Carolina, USA: GlaxoSmithKline, 2001"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510480064036"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Rollema H, Chambers LK, Coe JW, et al. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 2007:in press","DOI":"10.1016\/j.neuropharm.2006.10.016"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Ward MM, Swan GE, Jack LM. Self-reported abstinence effects in the first month after smoking cessation. Addict Behav 200126:311\u201327","DOI":"10.1016\/S0306-4603(00)00107-6"},{"key":"CIT0019","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington: American Psychiatric Association, 1995"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079907X182185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T04:12:26Z","timestamp":1598674346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079907X182185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,5]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4,1]]}},"alternative-id":["10.1185\/030079907X182185"],"URL":"https:\/\/doi.org\/10.1185\/030079907x182185","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,5]]}}}